API
< Back to all clusters
[HEALTH] · Israel, United States · 8 sources

started · updated

Viagra's active ingredient sildenafil shown to curb cancer metastasis

Researchers at Israel's Weizmann Institute of Science reported that sildenafil, the drug component of Viagra, can block the transport of cholesterol into tumor cells, a process essential for metastasis. Laboratory tests on human breast, lung and colon cancer cells showed reduced movement and growth, with the strongest effect in triple‑negative breast cancer. In mouse experiments, sildenafil cut the spread of tumors to the lungs by more than half.

An analysis of about five million patient records from Israel’s Clalit health system, spanning two decades, found that cancer patients who had used sildenafil faced a 26 % lower risk of dying within five years compared with non‑users. The benefit was even greater for patients who had taken both sildenafil and statins at least six months before a cancer diagnosis, showing higher survival rates. The study, published in the journal Cancer Research, also examined melanoma, colorectal and prostate cancers. The researchers plan clinical trials, especially in women with triple‑negative breast cancer, to confirm these findings.

Entities

Ayelet Erez · Clalit Health Services · Dr. Ayelet Erez · National Cancer Institute · National Cancer Institute (USA) · Sildenafil · Sildenafil (Viagra) · Statins · Statins · Weizmann Institute of Science

Claims

What the coverage asserts, and how many sources carry each claim.